Abstract
IDiabetes mellitus is a systemic disease that currently affects 6% of the population and ranks as the third most common disease.1 In the United States, 1 to 2 million of these people have type 1 diabetes mellitus, previously referred to as juvenile-onset diabetes.2 Type 1 diabetes is characterized by deficient insulin production due to destruction of insulin-producing beta cells in the pancreas. The etiology of this cell destruction has not been fully elucidated, but autoimmune attack, genetic factors, and environmental influences, including infectious agents, have all been implicated. Some insulin-deficient patients have glucose intolerance from loss of pancreas function following pancreatitis, with or without surgical pancreatic resection. Such patients are also insulin deficient and have many of the characteristics and complications seen in patients with autoimmune type 1 diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harris M, Hadden WC, Knowles WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population aged 20—74 years. Diabetes 1987;36:523–534.
Libman I, Songer T, Lapote R. How many people in the U.S. have IDDM? Diabetes Care 1993;16:841–842.
National Diabetes Data Group, National Institutes of Health. Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health; 1995.
Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328:1676–1684.
Selby JV, Fitzsimmons SC, Newman JM, et al. The natural history and epidemiology of diabetic nephropathy: implications for prevention and control. JAMA 1990;263:1954–1960.
American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296–309.
The Diabetes and Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
Munger B. Morphologic characterization of islet cell diversity. In: Cooperstein S, Watkins D, eds. The Islets of Langerhans: Biochemistry, Physiology, and Pathology. New York: Academic Press; 1981:3–34.
Gruessner AC, Sutherland DER. Analysis of United States and non-U. S. pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory; 1999:1–19.
Sollinger HW, Ploeg RJ, Eckhoff DE, et al. Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. Surgery 1993;114:736–744.
Kuo PC, Johnson LB, Schweitzer EJ, et al. Solitary pancreas allografts. Arch Surg 1997;132:52–57.
Venström JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003;290:2817–2833.
Gruessner RWG, Sutherland DER, Gruessner AC. Mortality assessment for pancreas transplants. Am J Transplant 2005;4:2018–2026.
Stratta RJ, Taylor RJ, Larsen JL, Cushing K. Pancreas transplantation. Int J Pancreatol 1995;17:1–13.
Schweitzer Ef, Anderson L, Kuo PC, et al. Safe pancreas transplantation in patients with coronary artery disease. Transplantation 1997;63:1294–1299.
Odorico JS, Heisey DM, Voss BJ, et al. Donor factors affecting outcome after pancreas transplantation. Transplant Proc 1998;30:276–277.
Doudzdjian V, Gugliuzza KG, Fish JC. Multivariate analysis of donor risk factors for pancreas allograft failure after simultaneous pancreas-kidney transplantation. Surgery 1995;118:73–81.
Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DER. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in multivariate analysis of a single institution’s experience. Ann Surg 1992;215:217–230.
Hesse UJ, Sutherland DER. Influence of serum amylase and plasma glucose levels in pancreas cadaver donors on graft function in recipients. Diabetes 1989;38(suppl 1):1–3.
Bunzendahl H, Ringe B, Meyer HJ, Gubernatis G, Pichlmayr R. Combination harvesting procedure for liver and whole pancreas. Transpl Int 1988;1:99–102.
Dunn DL, Morel P, Schlumpf R, et al. Evidence that combined procurement of pancreas and liver grafts does not affect transplant outcome. Transplantation 1991;51:150–157.
Belzer FO, D’Alessandro AM, Hoffman RM, et al. The use of UW solution in clinical transplantation. Ann Surg 1992;215:579–585.
Englesbe MJ, et al. Early pancreas outcomes with histidinetryptophan-ketoglutarate preservation: a multicenter study. Transplantation 2006;82:136–139.
Humar A, Gruessner RWG, Sutherland DER. Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 1997;53:879–891.
Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. J Clin Invest 1992;89:1761–1766.
Gruessner RW, Kendall DM, Drangstveit MB, Gruessner AC, Sutherland DE. Simultaneous pancreas-kidney transplantation from live donors. Ann Surg 1997;226:471–480.
Zieliski A, et al. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. Transplantation 2003;76:547–552.
Nymann T, Hathaway DK, Shokouh-Amiri MH, et al. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Clin Transplant 1998;12:175–183.
Stratta RJ, Gaber AO, Shokouh-Amiri MH, et al. A 9-year experience with 126 pancreas transplants with portal enteric drainage. Arch Surg 2001;136:1141–1149.
Gruessner AC, Sutherland DER. Pancreas transplants for United States and non-U. S. cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998:40–45.
Gaber AO, Shokouh-Amiri MH, Hathaway D, et al. Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 1995;221:613–624.
Losanoff JE, Harland RC, Thistlethwaite JR, et al. Omega jeju-noduodenal anastomosis for pancreas transplant. J Am Coll Surg 2005;202:1021–1024.
Demartinesa N, Schiessera M, Claviena PA. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 2005;5:2688–2697.
Sollinger HW, Stratta RJ, D’Alessandro AM, Kalayoglu M, Pirsch JD, Belzer FO. Experience with simultaneous pancreas-kidney transplantation. Ann Surg 1988;208:475–483.
Rosen B, Frohnert PP, Velosa JA, et al. Morbidity of pancreas transplant during cadaveric renal transplantation. Transplantation 1991;51:123–127.
Stratta RJ, Taylor RJ, Lowell JA, et al. OKT3 induction in 100 consecutive pancreas transplants. Transplant Proc 1994;55:509–516.
Sutherland DER, Gruessner A. Pancreas transplantation as reported to the United Network for Organ Sharing and analyzed by the International Pancreas Transplant Registry. Clinical Transplants 1995. Los Angeles: UCLA Tissue Typing Laboratory; 1996:49.
Kuo PC, Wong J, Schweitzer EJ, Johnson LB, Lim JW, Bartlett ST. Outcome after splenic vein thrombosis in the pancreas allograft. Transplantation 1997;64:933–935.
Troppman C, Gruessner MS, Dunn DL, Sutherland DER, Gruessner RWG. Surgical complications requiring early relaparotomy after pancreas transplantation. Ann Surg 1998;227:255–268.
DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 1994;40:191–201.
Elmer DS, Hathaway DK, Bashar Abdulkarim A, et al. Use of glucose disappearance rates (kG) to monitor endocrine function of pancreas allografts. Clin Transplant 1998;12:56–64.
Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy. Transplantation 1997;63:1579–1586.
Sutherland DER, Sibley RK, Xu XZ, et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type 1 diabetes. Trans Assoc Am Phys 1984;97:80–87.
Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 1989;38:85–87.
Sutherland DER, Gruessner RWG, Dunn DL, Moudry-Munns KC, Gruessner AC, Najarian JS. Pancreas transplants from living related donors. Transplant Proc 1994;26:443–445.
Benedetti E, Dunn T, Massad MG, et al. Successful living related simultaneous pancreas-kidney transplant between identical twins. Transplantation 1999;67:915–934.
Voltarelli JC, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568–1576.
D’Alessandro AM, Kalayoglu M, Hammes R, et al. Diagnosis of intestinal transplant rejection using technetium-99m-DTPA. Transplantation 1994;58:112–113.
Sollinger HW, Odorico JS, Knechtle SJ, D’Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998;228:284–296.
Gruessner AC, Sutherland DER. Pancreas transplants for United States and non-U.S. cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Clinical Transplants 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1998:40–45.
Bohman S-O, Wilsczek H, Tyden G, Jaremko G, Lundgren G, Groth CG. Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 1987;19:2290–2293.
Wilczek HE, Jaremko G, Tyden G, Groth CG. Evolution of diabetic nephropathy in kidney grafts: evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 1995;59:51–57.
el-Gebely S, Hathaway DK, Elmer DS, Gaber LW, Acchiardo S, Gaber AO. An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at 2 years following transplantation. Transplantation 1995;59:1410–1415.
Muller-Felber W, Landgraf R, Scheuer R, et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993;42:1482–1486.
Navarro X, Kennedy WR, Loewensen RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990;39:802–806.
Wang Q, Klein R, Moss SE, et al. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy: a case series. Ophthalmology 1994;101:1071–1076.
Sutherland DER, Kendall DM, Moudry KC, et al. Pancreas transplantation in nonuremic, type 1 diabetic recipients. Surgery 1988;104:453–464.
Gross CR, Limwattananon C, Matthees BJ. Quality of life after pancreas transplantation: a review. Clin Transplant 1998;12:351–361.
Milde FK, Hart LK, Zehr PS. Pancreatic transplantation: impact on the quality of life of diabetic renal transplant recipients. Diabetes Care 1995;18:93–95.
Wahoff DC, Papalois BE, Najarian JS, et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995;222:562–579.
Brendel M, et al. International Islet Transplant Registry Report. Giessen, Germany: University of Giessen; 1999.
Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230–238.
Ryan EA, Lakey JR, Rajotte RV, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001;50:710–719.
NCRR launches $10.4 million initiative to create islet cell resource centers. Transplant News 2001;11(20):4.
Bertuzzi F, Secchi A, DiCarlo V. Islet transplantation in type 1 diabetics. Transplant Proc 2004;36:603–604.
Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islet of Langerhans. Transplantation 1996;61:1047–1053.
Toso C, Oberholzer J, Ris F, et al. Factors affecting human islet of Langerhans isolation yields. Transplant Proc 2002;34:826–827.
Lakey JR, Kneteman NM, Rajotte RV, Wu DC, Bigam D, Shapiro AMJ. Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002;73:1106–1110.
Kawamura T, Kuroda Y, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new simple two layer (Euro-Collins’ solution/perfluorochemical) cold storage method for pancreas preservation. Transplant Proc 1989;21(1 pt 2):1376–1377.
Fujino Y, Kuroda Y, Suzuki Y, et al. Preservation of canine pancreas for 96 hours by a modified two-layer (UW solution/ perfluorochemical) cold storage method. Transplantation 1991;51:1133–1135.
Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988;46:457–460.
Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003;3:53–63.
Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002;74:1804–1809.
Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002;74:1809–1811.
Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003;75:1524–1527.
Lowe KC DM, Power JB. Perfluorochemicals: Their applications and benefits to cell culture. Trends Biotechnol 1998;16:272.
Lowe KC. Perfluorinated blood substitutes and artificial oxygen carriers. Blood Rev 1999;13:171–184.
D’Alessandro AM, Kalayoglu M, Sollinger FIW, Pirsch JD, Southard JH, Belzer FO. Current status of organ preservation with University of Wisconsin solution. Arch Pathol Lab Med 1991;115:306–310.
Palombo JD, Pomposelli JJ, Hirschberg Y, Blackburn GL, Bistrian BR. Glycolytic support of adenine nucleotides in rat liver flush-preserved with UW or Collins’ II. Importance of donor nutritional status. Transplantation 1989;48:901–905.
Southard JH, van Gulik TM, Ametani MS, et al. Important components of the UW solution. Transplantation 1990;49:251–257.
Kuroda Y, Fujino Y, Kawamura T, et al. Mechanism of oxygenation of pancreas during preservation by a two-layer (Euro-Collins’ solution/perfluorochemical) cold-storage method. Transplantation 1990;49:694–696.
Kuroda Y, Fujino Y, Morita A, et al. Successful 96-hour preservation of the canine pancreas. Transpl Int 1992;5(suppl 1):S388–S390.
Iwanaga Y, Suzuki Y, Okada Y, et al. Ultrastructural analyses of pancreatic grafts preserved by the two-layer cold-storage method and by simple cold storage in University of Wisconsin solution. Transpl Int 2002;15:425–430.
Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988;37:413–420.
Garfinkel MR, Connors M, Ostrega D, Jarosz J, Philipson L, Millis JM. Islet isolation under cGMP conditions: replacing the coil. Transplant Proc 2004;36:1031–1033.
Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293:830–836.
Brunicardi FC, Mullen Y. Issues in clinical islet transplantation. Pancreas 1994;9:281–290.
Larson-Wadd K, Belani KG. Pancreas and islet cell transplantation. Anesthesiol Clin North Am 2004;22:633–674.
Goss JA, Sokes G, Goodpator SE, et al. Pancreatic islet transplantation: the radiologic approach. Transplantation 2003;76:199–203.
Casey JJ, Lakey JRT, Ryan EA, et al. Portal venous pressure changes after sequential clinical islet transplantation. Transplantation 2002;74:913–915.
Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002;21:2148–2157.
Shapiro AMJ, Lakey JRT, Rajotte RV, et al. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet transplant. Transplantation 1995;59:1060–1063.
Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004;4:390–401.
Immune Tolerance Network. Preliminary Results of ITN Mul-ticenter Islet Transplant Trial Confirm Potential Patient Benefits, Underscore Steep Learning Curve. In: ITN News and Announcements; 2003.
Shapiro AMJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318–1330.
Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060–2069.
Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955–962.
Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741–750.
Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005;365:1642–1644.
Street CN, Sipione S, Helms L, et al. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes. Int J Biochem Cell Biol 2004;36:667–683.
deVos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002;45:159–173.
Sun Y, Ma X, Zhao D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417–1422.
Chick WL, et al. A hybrid artificial pancreas. Transam Soc Artif Internal Organs 1975;21:8–15.
Scharp DW, Mason NS, Sparks RE. Islet immunoisolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 1984;8:221–229.
Desai TA, Hansford DJ, Ferrari M. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol Eng 2000;17:23–36.
Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210:908–910.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Harland, R.C., Garfinkel, M.R. (2008). Pancreas and Islet Transplantation. In: Norton, J.A., et al. Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-68113-9_85
Download citation
DOI: https://doi.org/10.1007/978-0-387-68113-9_85
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30800-5
Online ISBN: 978-0-387-68113-9
eBook Packages: MedicineMedicine (R0)